XML 69 R48.htm IDEA: XBRL DOCUMENT v3.23.4
Stockholders’ Equity (Tables)
12 Months Ended
Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Plan and the Weighted Average Grant Price
A summary of the Performance, Executive, and Director Awards granted under the Stock Plan, and the weighted average grant prices, during the fiscal years ended October 31, is as follows:
202320222021
Number of SharesWeighted-Average Grant PriceNumber of SharesWeighted-Average Grant PriceNumber of SharesWeighted-Average Grant Price
Performance Awards79,972 $13.19 — $— — $— 
Executive Awards193,381 $14.87 70,000 $14.96 95,000 $15.26 
Director Awards22,836 $16.26 49,231 $13.55 30,663 $16.85 
Total296,189 $14.52 119,231 $14.38 125,663 $15.65 
Schedule of Nonvested Shares
A summary of the status of the Company’s nonvested shares as of October 31, 2023, and changes during fiscal year 2023, is presented below:
Number of SharesWeighted-Average
Grant Price
Nonvested at October 31, 2022110,897 $14.40 
Granted296,189 $14.52 
Vested(92,564)$14.29 
Nonvested at October 31, 2023314,522 $14.55